Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.

Dean T EurichCerina LeeArsene ZongoJasjett K Minhas-SandhuJohn G HanlonElaine HyshkaJason Dyck

Published in: Journal of epidemiology and community health (2019)

An initial increase (within first month) in healthcare utilisation may be expected among medical cannabis users that appears to wane over time. Proactive follow-up of patients using medical cannabis is warranted to minimise initial risks to patients and actively assess potential benefits/harms of ongoing use.

Keyphrases

healthcare
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
risk assessment
patient reported